IV Ensure

IV Ensure revolutionizes home infusion through its breakthrough Infusion Medication Adherence Platform (iMAP)™—HITRUST-certified solution transforming patient outcomes while reducing costs. Our mission: Transform home infusion by delivering value-based care for better patient outcomes. Through improved medication adherence, we strive to make a positive impact on the non-adherence healthcare challenge. The iMAP platform bridges the critical gap between hospital and home, creating connections where clinical isolation once existed. Our unique Tech + Touch solution delivers high medication adherence, ensuring provider confidence and better outcomes. A pioneer in home infusion, IV Ensure provides real-time support when patients need it most. This human connection creates the "Hawthorne Effect," bringing positive behavioral changes and delivering higher value-based care metrics. In a joint clinical study with the University of Oklahoma Medical Center, iMAP achieved: * 94% medication adherence * 68% reduction in infection-related readmissions at 90 days For payors, these outcomes translate to: * $100M+ savings per million lives * Eliminate costly readmissions * Improved value-based care, including better HEDIS measures and Star ratings For providers, iMAP delivers visibility and data-driven insights that lead to better patient outcomes. For patients, iMAP ensures successful home infusion, especially for those with complex health challenges, preventing costly readmissions and improving quality of life. By connecting all stakeholders in the home infusion ecosystem, IV Ensure creates an effective care team model for improved patient outcomes and better value-based care metrics. We are dedicated to advancing value-based care and delivering better patient outcomes across the healthcare continuum.